These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 1542259)

  • 21. Plasma LDL oxidation leads to its aggregation in the atherosclerotic apolipoprotein E-deficient mice.
    Maor I; Hayek T; Coleman R; Aviram M
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2995-3005. PubMed ID: 9409286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin II-modified LDL is taken up by macrophages via the scavenger receptor, leading to cellular cholesterol accumulation.
    Keidar S; Kaplan M; Aviram M
    Arterioscler Thromb Vasc Biol; 1996 Jan; 16(1):97-105. PubMed ID: 8548433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intensive combination drug therapy of familial hypercholesterolemia with lovastatin, probucol, and colestipol hydrochloride.
    Witztum JL; Simmons D; Steinberg D; Beltz WF; Weinreb R; Young SG; Lester P; Kelly N; Juliano J
    Circulation; 1989 Jan; 79(1):16-28. PubMed ID: 2642754
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retention of oxidized LDL by extracellular matrix proteoglycans leads to its uptake by macrophages: an alternative approach to study lipoproteins cellular uptake.
    Kaplan M; Aviram M
    Arterioscler Thromb Vasc Biol; 2001 Mar; 21(3):386-93. PubMed ID: 11231918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of lovastatin on concentrations and composition of lipoprotein subfractions.
    Nozaki S; Vega GL; Haddox RJ; Dolan ET; Grundy SM
    Atherosclerosis; 1990 Oct; 84(2-3):101-10. PubMed ID: 2282090
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro oxidised HDL exerts a cytotoxic effect on macrophages.
    Hurtado I; Fiol C; Gracia V; Caldú P
    Atherosclerosis; 1996 Aug; 125(1):39-46. PubMed ID: 8831925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of low density lipoprotein oxidation by thyronines and probucol.
    Hanna AN; Feller DR; Witiak DT; Newman HA
    Biochem Pharmacol; 1993 Feb; 45(3):753-62. PubMed ID: 8442772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reconstituted high density lipoprotein reduces the capacity of oxidatively modified low density lipoprotein to accumulate cholesteryl esters in mouse peritoneal macrophages.
    Sakai M; Miyazaki A; Hakamata H; Suginohara Y; Sakamoto YI; Morikawa W; Kobori S; Schichiri M; Horiuchi S
    Atherosclerosis; 1996 Jan; 119(2):191-202. PubMed ID: 8808496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HMG-CoA reductase inhibitors suppress macrophage growth induced by oxidized low density lipoprotein.
    Sakai M; Kobori S; Matsumura T; Biwa T; Sato Y; Takemura T; Hakamata H; Horiuchi S; Shichiri M
    Atherosclerosis; 1997 Aug; 133(1):51-9. PubMed ID: 9258407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of vitamin E, probucol, and lovastatin on oxidative status and aortic fatty lesions in hyperlipidemic-diabetic hamsters.
    El-Swefy S; Schaefer EJ; Seman LJ; van Dongen D; Sevanian A; Smith DE; Ordovas JM; El-Sweidy M; Meydani M
    Atherosclerosis; 2000 Apr; 149(2):277-86. PubMed ID: 10729377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of lovastatin and probucol in treatment of familial and non-familial hypercholesterolemia: different effects on lipoprotein profiles.
    Helve E; Tikkanen MJ
    Atherosclerosis; 1988 Aug; 72(2-3):189-97. PubMed ID: 3063268
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibitory effects of HepG2 cell-derived apolipoprotein A-I-containing lipoproteins on cholesteryl ester accumulation in macrophages.
    Kawano T; Hakamata H; Ohta T; Ding Y; Yoshida M; Ueda S; Horiuchi S
    Biochemistry; 1997 Aug; 36(32):9816-25. PubMed ID: 9245414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The contribution of the macrophage receptor for oxidized LDL to its cellular uptake.
    Aviram M
    Biochem Biophys Res Commun; 1991 Aug; 179(1):359-65. PubMed ID: 1883365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipoperoxidative injury to macrophages by oxidatively modified low density lipoprotein may play an important role in foam cell formation.
    Liu SX; Zhou M; Chen Y; Wen WY; Sun MJ
    Atherosclerosis; 1996 Mar; 121(1):55-61. PubMed ID: 8678924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro oxidised HDL is recognized by the scavenger receptor of macrophages: implications for its protective role in vivo.
    La Ville AE; Sola R; Balanya J; Turner PR; Masana L
    Atherosclerosis; 1994 Feb; 105(2):179-89. PubMed ID: 8003094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in the metabolism of oxidatively modified low density lipoprotein and acetylated low density lipoprotein by human endothelial cells: inhibition of cholesterol esterification by oxidatively modified low density lipoprotein.
    Jialal I; Chait A
    J Lipid Res; 1989 Oct; 30(10):1561-8. PubMed ID: 2614259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lovastatin therapy in receptor-negative homozygous familial hypercholesterolemia: lack of effect on low-density lipoprotein concentrations or turnover.
    Uauy R; Vega GL; Grundy SM; Bilheimer DM
    J Pediatr; 1988 Aug; 113(2):387-92. PubMed ID: 3397806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vastatins inhibit cholesterol ester accumulation in human monocyte-derived macrophages.
    Kempen HJ; Vermeer M; de Wit E; Havekes LM
    Arterioscler Thromb; 1991; 11(1):146-53. PubMed ID: 1987992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Red wine inhibits the cell-mediated oxidation of LDL and HDL.
    Rifici VA; Stephan EM; Schneider SH; Khachadurian AK
    J Am Coll Nutr; 1999 Apr; 18(2):137-43. PubMed ID: 10204829
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipoprotein lipase stimulates the binding and uptake of moderately oxidized low-density lipoprotein by J774 macrophages.
    Hendriks WL; van der Boom H; van Vark LC; Havekes LM
    Biochem J; 1996 Mar; 314 ( Pt 2)(Pt 2):563-8. PubMed ID: 8670071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.